SMi Group Ltd are pleased to welcome Prof. Gilberto De Nucci from University of Sao Paulo onto the 13th annual conference, Advances and Progress in Drug Design.
LONDON, United Kingdom -
(EINPresswire via NewMediaWire) - January 21, 2014 - Dr. De Nucci is a member of the Brazilian Academy of Medicine and one of the most highly cited biomedical scientists in the world, according to the Institute for Scientific Information. He has a prolific output, with more than 200 papers published in international peer-reviewed journals.
Professor Nucci will be joined by key industry experts and leading pioneers from across the world to discuss, debate and share ideas and challenges facing the drug design arena.Advances and Progress in Drug Design has been a premier event in its field for more than a decade and will feature a truly global audience from; Brazil, Denmark, Finland, France, Germany, Greece, Hungary, Kuwait, Netherlands, Sweden, Switzerland, United Kingdom and USA.
Key Speakers will include:
• Huafeng Xu, Computational Chemist, D. E. Shaw Research
• John Mathias, Head of Medicinal Chemistry - Inflammation & Remodelling, Pfizer
• Harald Mauser, Computational Medicinal Chemist, Molecular Design and Chemical Biology, Roche
• Sudharsan Sridharan, Scientist, MedImmune
• Tom Heightman, Senior Director, Astex Pharmaceuticals
• Amaury Ernesto Fernandez-Montalvan, Lab Head, High Throughput Screening, Bayer HealthCare Pharmaceuticals
• Karl-Heinz Baringhaus, Site Director, R&D Frankfurt, Sanofi-Aventis
• Dr Neil Press, Director, Novartis
• Andrea Bortolato, Senior Computational Chemistry, Heptares Therapeutics
• Paul Brennan, Group Head/PI, Nuffield Department of Medicine
Visit the conference homepage to download a brochure and see the full speaker line—up for 2014 at:
www.drug-design.co.uk
With just 4 weeks to go registration will be closing soon. For those interested in attending register online here
Advances & Progress in Drug Design
17th – 18th February 2014
Marriott Regents Park Hotel
London, UK
Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162